Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer

R. Iacovelli, M. Cossu Rocca, L. Galli, U. De Giorgi, R. Sabbatini, M. Santoni, A. Mosca, G. Fornarini, F. Massari, C. Masini, M. Bersanelli, E. Biasco, C. Lolli, A. Guida, R. Berardi, C. Terrone, A. Pastorino, A. Ardizzoni, C. Pinto, S. ButiF. Nolè, G. Tortora

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)541.e7-541.e13
JournalUrologic Oncology: Seminars and Original Investigations
Volume35
Issue number9
DOIs
Publication statusPublished - 2017

Cite this

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer. / Iacovelli, R.; Cossu Rocca, M.; Galli, L.; De Giorgi, U.; Sabbatini, R.; Santoni, M.; Mosca, A.; Fornarini, G.; Massari, F.; Masini, C.; Bersanelli, M.; Biasco, E.; Lolli, C.; Guida, A.; Berardi, R.; Terrone, C.; Pastorino, A.; Ardizzoni, A.; Pinto, C.; Buti, S.; Nolè, F.; Tortora, G.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 35, No. 9, 2017, p. 541.e7-541.e13.

Research output: Contribution to journalArticle

Iacovelli, R. ; Cossu Rocca, M. ; Galli, L. ; De Giorgi, U. ; Sabbatini, R. ; Santoni, M. ; Mosca, A. ; Fornarini, G. ; Massari, F. ; Masini, C. ; Bersanelli, M. ; Biasco, E. ; Lolli, C. ; Guida, A. ; Berardi, R. ; Terrone, C. ; Pastorino, A. ; Ardizzoni, A. ; Pinto, C. ; Buti, S. ; Nolè, F. ; Tortora, G. / Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer. In: Urologic Oncology: Seminars and Original Investigations. 2017 ; Vol. 35, No. 9. pp. 541.e7-541.e13.
@article{226bc805d188409b84a7d217a257e63b,
title = "Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer",
author = "R. Iacovelli and {Cossu Rocca}, M. and L. Galli and {De Giorgi}, U. and R. Sabbatini and M. Santoni and A. Mosca and G. Fornarini and F. Massari and C. Masini and M. Bersanelli and E. Biasco and C. Lolli and A. Guida and R. Berardi and C. Terrone and A. Pastorino and A. Ardizzoni and C. Pinto and S. Buti and F. Nol{\`e} and G. Tortora",
note = "Cited By :1 Export Date: 5 March 2018",
year = "2017",
doi = "10.1016/j.urolonc.2017.05.007",
language = "English",
volume = "35",
pages = "541.e7--541.e13",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer

AU - Iacovelli, R.

AU - Cossu Rocca, M.

AU - Galli, L.

AU - De Giorgi, U.

AU - Sabbatini, R.

AU - Santoni, M.

AU - Mosca, A.

AU - Fornarini, G.

AU - Massari, F.

AU - Masini, C.

AU - Bersanelli, M.

AU - Biasco, E.

AU - Lolli, C.

AU - Guida, A.

AU - Berardi, R.

AU - Terrone, C.

AU - Pastorino, A.

AU - Ardizzoni, A.

AU - Pinto, C.

AU - Buti, S.

AU - Nolè, F.

AU - Tortora, G.

N1 - Cited By :1 Export Date: 5 March 2018

PY - 2017

Y1 - 2017

U2 - 10.1016/j.urolonc.2017.05.007

DO - 10.1016/j.urolonc.2017.05.007

M3 - Article

VL - 35

SP - 541.e7-541.e13

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 9

ER -